Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma

doi:10.3748/wjg.v18.i12.1379

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4438)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

568

HTML

3473

Figures (1-2)

193

Tables (1-1)

204

Sum=4438

Mar 28, 2012 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 28, 2012; 18(12): 1379-1384
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1379

Open in New Tab Full Size Figure Download Figure

Figure 1 Overall comparison of changes in Child-Pugh score between the branched-chain amino acids group and the control group over time. There was a significant difference in changes in Child-Pugh score 3 and 6 mo after transcatheter arterial chemoembolization. ^aP < 0.05 vs control group. BCAA: Branched-chain amino acid.

Open in New Tab Full Size Figure Download Figure

Figure 2 Comparison of changes in Child-Pugh score in Child A and Child B patients: patients with a serum albumin level of 3. 5 g/dL or more, low-dose epirubicin subgroups, high-dose epirubicin subgroups. A: A significant difference was noted in changes in Child-Pugh score 3 and 6 mo after transcatheter arterial chemoembolization; B: A significant difference was noted in changes in Child-Pugh score 1, 3 and 6 mo after transcatheter arterial chemoembolization; C: A significant difference was observed in changes in Child-Pugh score 3 and 6 mo after TACE; D: A significant difference was noted in changes in Child-Pugh score 3 and 6 mo after TACE; E: A significant difference was noted in changes in Child-Pugh score 3 and 6 mo after TACE. BCAA: Branched-chain amino acids; TACE: Transcatheter arterial chemoembolization. ^aP < 0.05 vs control group.

Citation: Nishikawa H, Osaki Y, Inuzuka T, Takeda H, Nakajima J, Matsuda F, Henmi S, Sakamoto A, Ishikawa T, Saito S, Kita R, Kimura T. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2012; 18(12): 1379-1384
URL: https://www.wjgnet.com/1007-9327/full/v18/i12/1379.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i12.1379